Mengis Capital Management, Inc. - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 911 filers reported holding NOVARTIS A G in Q1 2017. The put-call ratio across all filers is 2.34 and the average weighting 0.5%.

Quarter-by-quarter ownership
Mengis Capital Management, Inc. ownership history of NOVARTIS A G
ValueSharesWeighting
Q2 2024$8,687,668
+7.2%
81,605
-2.6%
1.76%
+40.9%
Q1 2024$8,105,296
-2.0%
83,793
+2.3%
1.25%
-19.4%
Q4 2023$8,273,784
-0.5%
81,943
+0.4%
1.55%
-10.2%
Q3 2023$8,316,155
+0.9%
81,643
-0.1%
1.73%
+5.0%
Q2 2023$8,243,640
+9.5%
81,693
-0.2%
1.64%
+3.7%
Q1 2023$7,531,856
+100836.2%
81,868
-0.5%
1.59%
-2.5%
Q4 2022$7,462
-99.9%
82,258
-0.6%
1.63%
+9.2%
Q3 2022$6,288,000
-13.4%
82,728
-3.6%
1.49%
-6.5%
Q2 2022$7,257,000
-3.8%
85,861
-0.2%
1.59%
+10.2%
Q1 2022$7,546,000
+1.5%
85,996
+1.1%
1.45%
+3.6%
Q4 2021$7,437,000
+10.0%
85,029
+2.8%
1.40%
-1.7%
Q3 2021$6,761,000
-10.1%
82,679
+0.3%
1.42%
-8.9%
Q2 2021$7,520,000
+9.0%
82,429
+2.1%
1.56%
+2.0%
Q1 2021$6,901,000
-0.4%
80,742
+10.0%
1.53%
-9.2%
Q4 2020$6,928,000
+8.7%
73,369
+0.1%
1.68%
-3.8%
Q3 2020$6,376,000
+1.3%
73,325
+1.7%
1.75%
-6.5%
Q2 2020$6,296,000
+6.0%
72,092
+0.0%
1.87%
-7.9%
Q1 2020$5,942,000
-8.6%
72,070
+5.0%
2.03%
+13.4%
Q4 2019$6,498,000
+8.4%
68,630
-0.5%
1.79%
+0.3%
Q3 2019$5,992,000
-4.9%
68,963
-0.1%
1.78%
-7.4%
Q2 2019$6,301,000
+149.8%
69,013
+163.0%
1.93%
+36.9%
Q1 2019$2,522,000
+11.7%
26,240
-0.3%
1.41%
-1.6%
Q4 2018$2,257,000
-0.8%
26,310
-0.4%
1.43%
+14.5%
Q3 2018$2,275,000
+12.9%
26,410
-1.0%
1.25%
+4.9%
Q2 2018$2,015,000
-6.4%
26,685
+0.2%
1.19%
-7.5%
Q1 2018$2,153,000
-3.7%
26,6350.0%1.29%
-4.9%
Q4 2017$2,236,000
+0.6%
26,635
+2.9%
1.35%
-9.1%
Q3 2017$2,222,000
+7.4%
25,885
+4.4%
1.49%
+1.6%
Q2 2017$2,068,000
+28.0%
24,785
+13.8%
1.46%
+23.8%
Q1 2017$1,616,00021,7701.18%
Other shareholders
NOVARTIS A G shareholders Q1 2017
NameSharesValueWeighting ↓
Martin Investment Management, LLC 318,637$27,960,0007.08%
MANAGED ASSET PORTFOLIOS, LLC 417,183$36,608,0005.02%
SAL Trading, LLC 233,600$20,498,0004.77%
SCHARF INVESTMENTS, LLC 1,340,680$117,662,0003.49%
SAL Trading, LLC 155,783$13,670,0003.18%
First Fiduciary Investment Counsel, Inc. 169,371$14,862,0002.90%
PRENTISS SMITH & CO INC 55,026$4,829,0002.90%
GARLAND CAPITAL MANAGEMENT INC 47,630$4,180,0002.77%
Cullen Capital Management, LLC 3,295,271$289,160,0002.66%
WILKINS INVESTMENT COUNSEL INC 133,880$11,748,0002.65%
View complete list of NOVARTIS A G shareholders